Is osteoporosis a peculiar association with primary biliary cirrhosis

AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population, (2) to id...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 11; no. 34; pp. 5347 - 5350
Main Author Floreani, Annarosa
Format Journal Article
LanguageEnglish
Published United States Department of Surgical and Gastroenterological Sciences, University of Padova,Italy%Department of Medical and Surgical Sciences, University of Padova, Italy%Department of Public Health, University of Padova, Italy%Department of Clinical Chemistry, University of Padova, Italy 14.09.2005
Baishideng Publishing Group Inc
Subjects
Online AccessGet full text
ISSN1007-9327
2219-2840
DOI10.3748/wjg.v11.i34.5347

Cover

Loading…
Abstract AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population, (2) to identify the main risk factors for the development of bone loss. METHODS: Thirty-five stage IV PBC patients (mean age 52.5±10 years), 49 females with HCV-related cirrhosis (mean age 52.9±5.8 years) and 33 healthy females (mean age 51.8±2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocaldn. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry. RESULTS: Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related drrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI〈23, and old age were independent variables significantly correlated with osteoporosis. CONCLUSION: PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age.
AbstractList (1) To compare the prevalence of osteoporosis (t-score < or =-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss. Thirty-five stage IV PBC patients (mean age 52.5+/-10 years), 49 females with HCV-related cirrhosis (mean age 52.9+/-5.8 years) and 33 healthy females (mean age 51.8+/-2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry. Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI <23, and old age were independent variables significantly correlated with osteoporosis. PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age.
AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population, (2) to identify the main risk factors for the development of bone loss. METHODS: Thirty-five stage IV PBC patients (mean age 52.5±10 years), 49 females with HCV-related cirrhosis (mean age 52.9±5.8 years) and 33 healthy females (mean age 51.8±2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocaldn. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry. RESULTS: Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related drrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI〈23, and old age were independent variables significantly correlated with osteoporosis. CONCLUSION: PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age.
(1) To compare the prevalence of osteoporosis (t-score < or =-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss.AIM(1) To compare the prevalence of osteoporosis (t-score < or =-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss.Thirty-five stage IV PBC patients (mean age 52.5+/-10 years), 49 females with HCV-related cirrhosis (mean age 52.9+/-5.8 years) and 33 healthy females (mean age 51.8+/-2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry.METHODSThirty-five stage IV PBC patients (mean age 52.5+/-10 years), 49 females with HCV-related cirrhosis (mean age 52.9+/-5.8 years) and 33 healthy females (mean age 51.8+/-2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry.Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI <23, and old age were independent variables significantly correlated with osteoporosis.RESULTSOsteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI <23, and old age were independent variables significantly correlated with osteoporosis.PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age.CONCLUSIONPBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age.
AIM: (1) To compare the prevalence of osteoporosis ( t -score ≤ -2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss. METHODS: Thirty-five stage IV PBC patients (mean age 52.5 ± 10 years), 49 females with HCV-related cirrhosis (mean age 52.9 ± 5.8 years) and 33 healthy females (mean age 51.8 ± 2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin. Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry. RESULTS: Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%), without any statistical difference between the two groups. Among healthy control subjects, none had osteoporosis. No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI < 23, and old age were independent variables significantly correlated with osteoporosis. CONCLUSION: PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age.
R5; AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage Ⅳ PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss.METHODS: Thirty-five stage Ⅳ PBC patients (mean age 52.5±10 years), 49 females with HCV-related cirrhosis (mean age 52.9±5.8 years) and 33 healthy females (mean age 51.8+2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin.Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry.RESULTS: Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%),without any statistical difference between the two groups.Among healthy control subjects, none had osteoporosis.No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI <23, and old age were independent variables significantly correlated with osteoporosis.CONCLUSION: PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age.
Author Annarosa Floreani Andrea Mega Valentina Camozzi Vincenzo Baldo Mario Plebani Patrizia Burra Giovanni Luise Luisetto
AuthorAffiliation Department of Surgical and Gastroenterological Sciences, University of Padova,Italy Department of Medicaland Surgical Sciences, University of Padova, Italy Department of Public Health, University of Padova, Italy Department of Clinical Chemistry, University of Padova, Italy
AuthorAffiliation_xml – name: Department of Surgical and Gastroenterological Sciences, University of Padova,Italy%Department of Medical and Surgical Sciences, University of Padova, Italy%Department of Public Health, University of Padova, Italy%Department of Clinical Chemistry, University of Padova, Italy
Author_xml – sequence: 1
  givenname: Annarosa
  surname: Floreani
  fullname: Floreani, Annarosa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16149144$$D View this record in MEDLINE/PubMed
BookMark eNp9UcFu1DAUtFAR3ZbeOaEIIW5Znu2XxL4gVVWBSpW4wNlyHGfXS9be2klX_XscdqEtB07v8GbmzZs5Iyc-eEvIGwpL3qD4uN-slveULh3HZcWxeUEWjFFZMoFwQhYUoCklZ80pOUtpA8A4r9grckpripIiLsj1TSpCGm3YhRiSS4UudtZMg9Ox0CkF4_Togi_2blwXu-i2Oj4UrZv3D4VxMa5n1mvystdDshfHeU5-fL7-fvW1vP325ebq8rY0WMFYdqzthLRYoZCyl9y0ViITHc0ejUTgTdt1tOo19hyZrSqwiLzTum1BQ9_wc_LpoLub2q3tjPVj1IM6-lJBO_V8491arcK9wpoxAbPA-4PAXvte-5XahCn6bFnlKBlADhFonWEfjndiuJtsGtXWJWOHQXsbpqRqUdVM8Fnv7VNDf538CTgD4AAwOd4Ubf8IATV3OB9WuUOVO1Rzh5lS_0MxbvzdQn7JDf8jvjsS18Gv7lx-r9XmZ-8GqxggF3XN-C-vTq8c
CitedBy_id crossref_primary_10_1007_s00774_007_0833_1
crossref_primary_10_1111_jgh_13062
crossref_primary_10_1371_journal_pone_0194418
crossref_primary_10_1016_j_cgh_2006_10_015
crossref_primary_10_1097_MCG_0b013e318032388d
crossref_primary_10_3748_wjg_v12_i22_3537
crossref_primary_10_2165_00024677_200605050_00004
crossref_primary_10_1002_hep_26696
crossref_primary_10_1016_j_cgh_2009_01_011
crossref_primary_10_3390_nu8060319
crossref_primary_10_3748_wjg_v29_i29_4580
crossref_primary_10_1007_s10067_017_3844_x
crossref_primary_10_1007_s12519_017_0013_x
crossref_primary_10_1002_iid3_1258
crossref_primary_10_1016_j_transproceed_2007_06_093
Cites_doi 10.1053/jhep.2001.20533
10.1016/s0168-8278(01)81646-9
10.1016/S1297-319X(02)00364-0
10.1016/S0168-8278(99)80167-6
10.1016/S0168-8278(01)00144-1
10.1016/S0016-5085(03)01060-6
10.1159/000171456
10.1016/S0016-5085(00)70423-9
10.1136/gut.31.1.82
10.1002/lt.500040413
10.7326/0003-4819-103-6-855
10.1210/jcem-69-6-1234
10.1136/gut.49.2.282
10.1136/bmj.310.6991.1357
10.1172/JCI117959
10.1002/hep.1840210138
10.1002/jbmr.5650111203
10.1016/S0168-8278(03)00143-0
10.1016/S1590-8658(03)00078-1
ClassificationCodes R5
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved. 2005
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
– notice: The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved. 2005
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
5PM
DOI 10.3748/wjg.v11.i34.5347
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Is osteoporosis a peculiar association with primary biliary cirrhosis
EISSN 2219-2840
EndPage 5350
ExternalDocumentID PMC4622807
wjg200534016
16149144
10_3748_wjg_v11_i34_5347
20438662
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: 教育部高等院校资助项目
GroupedDBID ---
123
29R
2B.
2C~
2RA
2WC
36B
53G
5VR
8WL
92F
92I
92L
93N
93R
AAKDD
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CDYEO
CHBEP
CIEJG
CQIGP
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
EMB
F5P
FA0
FRP
GX1
HYE
M~E
OK1
P2P
RNS
RPM
SV3
TCJ
TGQ
TR2
W91
WFFXF
XSB
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
4A8
PSX
5PM
ID FETCH-LOGICAL-c450t-d2bd89e454899f93cbe9428d1932c94037bdd15fa4f342e550e443daabb0a0f73
ISSN 1007-9327
IngestDate Thu Aug 21 18:13:41 EDT 2025
Thu May 29 04:01:26 EDT 2025
Fri Jul 11 08:40:37 EDT 2025
Wed Oct 16 00:47:23 EDT 2024
Tue Jul 01 01:54:00 EDT 2025
Thu Apr 24 23:03:33 EDT 2025
Fri Nov 25 19:17:12 EST 2022
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 34
Keywords Osteoporosis
Primary biliary cirrhosis
HCV infection
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c450t-d2bd89e454899f93cbe9428d1932c94037bdd15fa4f342e550e443daabb0a0f73
Notes Osteoporosis
Primary biliary cirrhosis
Osteoporosis; Primary biliary cirrhosis; HCV infection
HCV infection
14-1219/R
R575.7
R681
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Correspondence to: Professor Annarosa Floreani, Div. Gastroenterologia, Via Giustiniani, 2, Padova 35128, Italy. annarosa.floreani@unipd.it
Telephone: +39-49-8212894 Fax: +39-49-8760820
Author contributions: All authors contributed equally to the work.
OpenAccessLink https://www.wjgnet.com/1007-9327/full/v11/i34/5347.htm
PMID 16149144
PQID 68562837
PQPubID 23479
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4622807
wanfang_journals_wjg200534016
proquest_miscellaneous_68562837
pubmed_primary_16149144
crossref_primary_10_3748_wjg_v11_i34_5347
crossref_citationtrail_10_3748_wjg_v11_i34_5347
chongqing_backfile_20438662
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2005-09-14
PublicationDateYYYYMMDD 2005-09-14
PublicationDate_xml – month: 09
  year: 2005
  text: 2005-09-14
  day: 14
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World Journal of Gastroenterology
PublicationTitle_FL WORLD JOURNAL OF GASTROENTEROLOGY
PublicationYear 2005
Publisher Department of Surgical and Gastroenterological Sciences, University of Padova,Italy%Department of Medical and Surgical Sciences, University of Padova, Italy%Department of Public Health, University of Padova, Italy%Department of Clinical Chemistry, University of Padova, Italy
Baishideng Publishing Group Inc
Publisher_xml – name: Department of Surgical and Gastroenterological Sciences, University of Padova,Italy%Department of Medical and Surgical Sciences, University of Padova, Italy%Department of Public Health, University of Padova, Italy%Department of Clinical Chemistry, University of Padova, Italy
– name: Baishideng Publishing Group Inc
References ref13
ref12
ref15
ref14
ref20
ref11
ref22
ref10
ref21
ref2
ref1
ref17
ref16
ref19
ref18
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref13
– ident: ref10
  doi: 10.1053/jhep.2001.20533
– ident: ref6
– ident: ref22
  doi: 10.1016/s0168-8278(01)81646-9
– ident: ref18
  doi: 10.1016/S1297-319X(02)00364-0
– ident: ref11
  doi: 10.1016/S0168-8278(99)80167-6
– ident: ref3
  doi: 10.1016/S0168-8278(01)00144-1
– ident: ref2
  doi: 10.1016/S0016-5085(03)01060-6
– ident: ref7
  doi: 10.1159/000171456
– ident: ref9
  doi: 10.1016/S0016-5085(00)70423-9
– ident: ref12
  doi: 10.1136/gut.31.1.82
– ident: ref4
  doi: 10.1002/lt.500040413
– ident: ref14
  doi: 10.7326/0003-4819-103-6-855
– ident: ref15
  doi: 10.1210/jcem-69-6-1234
– ident: ref5
  doi: 10.1136/gut.49.2.282
– ident: ref20
  doi: 10.1136/bmj.310.6991.1357
– ident: ref16
  doi: 10.1172/JCI117959
– ident: ref8
  doi: 10.1002/hep.1840210138
– ident: ref21
  doi: 10.1002/jbmr.5650111203
– ident: ref1
  doi: 10.1016/S0168-8278(03)00143-0
– ident: ref17
– ident: ref19
  doi: 10.1016/S1590-8658(03)00078-1
SSID ssj0023352
Score 1.8689766
Snippet AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with...
(1) To compare the prevalence of osteoporosis (t-score < or =-2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one with...
R5; AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage Ⅳ PBC patients, and two groups of age- and sex-matched controls: one...
AIM: (1) To compare the prevalence of osteoporosis ( t -score ≤ -2.5 SD) between stage IV PBC patients, and two groups of age- and sex-matched controls: one...
SourceID pubmedcentral
wanfang
proquest
pubmed
crossref
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5347
SubjectTerms Adult
Brief Reports
Female
Hepatitis C, Chronic - epidemiology
Humans
Liver Cirrhosis - epidemiology
Liver Cirrhosis, Biliary - epidemiology
Middle Aged
Osteoporosis - epidemiology
Prevalence
Risk Factors
临床表现
原发性胆硬化
并发症
病理机制
骨质疏松症
Title Is osteoporosis a peculiar association with primary biliary cirrhosis
URI http://lib.cqvip.com/qk/84123X/200534/20438662.html
https://www.ncbi.nlm.nih.gov/pubmed/16149144
https://www.proquest.com/docview/68562837
https://d.wanfangdata.com.cn/periodical/wjg200534016
https://pubmed.ncbi.nlm.nih.gov/PMC4622807
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgCIkXBOKrjEEeeEFVujS5fD0hhFa2aRsv7eibZTtO2zGSkXZM6l_PXeLmo0N8vaRV6jiuf2f77nz3M2NvA61AgFK2G0ttQwDSlkL5Ni6uMohwyQBNDv3Ts-BwAsdTf9ocb1Vml6zkQK1_mVfyP6jiPcSVsmT_Adm6UryB3xFfvCLCeP0rjI-WfcrRyFGHzolYRPSv6KzbhSj6oun2ytd6ZWglKBiWPtWiKOb01FZoXxVd0yKUmInlqsiJurOo-JrIifDl-FODfI6KZ3kyVJ_omLEp9VR_qo3flsImm5gg8S1fr8sHzgWteuYI78qjepmU3tvzBYpjts47bgmfYiiqdFAzk5IPFJXDsDPVDlsiZZyY1cTpexXx5vaMTuw4CMPNxWzwYzgcLDwYbIp2ybPPPvPR5OSEjw-m47vsnotWg7Nx3hj7m9LLys1v07Jq15resL9dPzFtzPNs9h31h67GcssMuR1Ne_9GZKnIZi1FZfyIPTQWhvWhEpfH7I7OnrDR0dJqi4olrI2oWC1RsUhULCMqlhEVqxaV90_ZZHQw_nhomyM0bAW-s7ITVyZRrAHt0jhOY09JHaPBmZDarmJwvFAmydBPBaQeuBrNVQ3gJUJI6QgnDb1nbCfLM_2CWeAmqSsSBVIApIJytNEWCAVWqPzIc3pst-4yVMHUVyIW45R6HQWB22P7m07kyrDP0yEolxytUIKAIwQcIeAIAScIeuxd_YT5378p-2aDC8fpkfa8RKbz6yUPIlTwIw9LPK9QaupCxTQeAvRY2MGvLkDE691fssW8JGCHoCSR6rE9gzQ3o3JJLaPR4AGaUi__2Kpd9qAZO6_Yzqq41nuo5K7k61J0fwLWNK3M
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+osteoporosis+a+peculiar+association+with+primary+biliary+cirrhosis%3F&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Floreani%2C+Annarosa&rft.au=Mega%2C+Andrea&rft.au=Camozzi%2C+Valentina&rft.au=Baldo%2C+Vincenzo&rft.date=2005-09-14&rft.issn=1007-9327&rft.volume=11&rft.issue=34&rft.spage=5347&rft_id=info:doi/10.3748%2Fwjg.v11.i34.5347&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fwjg%2Fwjg.jpg